about
Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-upNon-celiac gluten sensitivity: a critical review of current evidenceA genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300[Inappropriateness rate for colonoscopy indications in an open access unit].Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry.Sugar malabsorption in functional abdominal bloating: a pilot study on the long-term effect of dietary treatment.Intestinal intraepithelial lymphocyte cytometric pattern is more accurate than subepithelial deposits of anti-tissue transglutaminase IgA for the diagnosis of celiac disease in lymphocytic enteritis.Evaluation of 5 versus 10 granulocyteaphaeresis sessions in steroid-dependent ulcerative colitis: a pilot, prospective, multicenter, randomized studyChanges of the mucosal n3 and n6 fatty acid status occur early in the colorectal adenoma-carcinoma sequenceAntineutrophil cytoplasmic antibodies in sera from colectomised ulcerative colitis patients and its relation to the presence of pouchitisIntracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis.Accuracy of GastroPanel for the diagnosis of atrophic gastritis.Drug consumption and the risk of microscopic colitis.The prevalence of coeliac disease is significantly higher in children compared with adults.Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial.Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxisDouble-Blind Randomized Clinical Trial: Gluten versus Placebo Rechallenge in Patients with Lymphocytic Enteritis and Suspected Celiac DiseaseEffectiveness of infliximab after adalimumab failure in Crohn's diseaseSevere ulcerative colitis: at what point should we define resistance to steroids?Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.Fructose-sorbitol malabsorption.Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.Is a gluten-free diet necessary in Marsh I intestinal lesions in patients with HLADQ2, DQ8 genotype and without gastrointestinal symptoms?Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.Systematic Review and Meta-analysis Show 3% of Patients With Celiac Disease in Spain to be Negative for HLA-DQ2.5 and HLA-DQ8.Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: a population-based study.Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease.Prevalence and Natural History of Microscopic Colitis: A Population-Based Study With Long-term Clinical Follow-up in Terrassa, Spain.Potential coeliac disease markers and autoimmunity in olmesartan induced enteropathy: A population-based study.Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3).Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.Intestinal permeability and statistics.Impact of current smoking on the clinical course of microscopic colitis.Letter: mucosal healing and mortality in coeliac disease.Vitamin status in patients with inflammatory bowel disease.Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status.Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era.Low serum selenium concentration in a healthy population resident in Catalunya: a preliminary report.Diagnosis of tuberculosis infection by tuberculin skin test and a whole-blood interferon-γ release assay in patients considered for anti-tumor necrosis factor-α therapy.
P50
Q28210198-633A9529-1F67-48F2-8EEB-6858D944F66FQ28236729-4E5B0751-D608-4FD0-9BD7-C5180AAE4A01Q28943442-6758ADF6-8633-4D81-93E3-01275DB0769AQ30487700-F01606F2-3566-4EF8-B3AD-44096CEA217CQ30992292-5C4E382B-C354-42F5-B5BD-FDC750E8FAA2Q33434608-F63BC373-7D57-48EB-92DE-72B5D2569243Q33881583-44E586DC-BF3A-4239-A0F5-EC613A74278DQ34098893-155BF286-44B7-4100-9071-E18E8E241B19Q34409322-DB2A6EFD-4B1A-4983-A425-E2025FE8E2B4Q34409834-66EEA5CA-AB89-4A97-80EF-7899C46CC557Q34409842-BD905402-E670-402D-A242-E7EA5161D383Q34512994-3BD63BAC-AF20-49B7-88B3-4F35F322CC5BQ34572501-292E2F31-05D0-4F47-B92C-EA6F0AD500D5Q34625864-6CFDD85F-3234-4489-99C6-AAB650A649F7Q35594810-84982E9F-4A64-4134-A427-5CFD3D571687Q35596827-801B85AE-B027-458C-AF62-45B618FF2C5BQ36071745-E7C71A16-BD7F-4F94-A800-3DA97D5879F1Q36310429-A5A44C1F-3131-4405-8251-A95C5D64B209Q37276951-7C8A6168-35D0-4231-A6DA-ACDB1B192AB8Q37330452-ACC342EF-0EDA-44CD-BD1C-FC88AF3780FEQ37599995-1BA22E6E-9EF4-42EE-953E-6DD59C8FDD73Q37854550-8DA8451F-4187-47C1-AC83-54277D155B16Q38033395-25B8C4C8-B8D7-4394-8FD3-B5637362B6B9Q38194708-67FCDC9A-404A-43EF-BC63-2F7D17E5809AQ38982071-B6ED239D-B5D1-4843-B557-F1A441006AC3Q39952656-F6F3D19E-53F4-416D-9719-97DB685A5B07Q40932469-BF474B94-6512-4D81-8ACA-B151178E4A78Q40946600-4D1BFBE2-E87F-41A1-AC21-44FBECAC862AQ41025490-91ECCBB3-6A76-4902-A883-1E4DBA6E5967Q42204495-BA90491C-7530-48CA-9A02-0E3A03351F55Q42997987-8471052C-7E65-45C1-8CE1-04358F1241D4Q43204546-DED5D2F9-1FC7-4E7D-81D5-E0662BC8BE29Q43674068-E264480B-79F2-4DBF-924D-5EBD3770BEC5Q43797216-A017C0D7-A0AB-46F6-A7BD-FAC14B477822Q43869748-04A8730A-A371-4073-8A36-D0BE3DF26CB7Q44110712-CAFFDC6F-F579-4B60-9910-C17F431481AEQ44144568-0520EB28-93CD-4D00-A9B4-C76ECFEBDBA2Q44596777-5D95CFF3-61FC-493D-9012-440F96AC5B9AQ44616222-F6DAE01D-BC43-4B0B-B60A-1C3D0FD46A1BQ45018309-1110F013-4F36-49A8-9DAE-E831B8B91BC8
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria Esteve
@ast
Maria Esteve
@en
Maria Esteve
@es
Maria Esteve
@nl
Maria Esteve
@sl
type
label
Maria Esteve
@ast
Maria Esteve
@en
Maria Esteve
@es
Maria Esteve
@nl
Maria Esteve
@sl
prefLabel
Maria Esteve
@ast
Maria Esteve
@en
Maria Esteve
@es
Maria Esteve
@nl
Maria Esteve
@sl
P106
P21
P31
P496
0000-0001-7716-0027